Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2008 1
2009 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 1
2020 1
2021 4
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
Shrotri M, Krutikov M, Palmer T, Giddings R, Azmi B, Subbarao S, Fuller C, Irwin-Singer A, Davies D, Tut G, Lopez Bernal J, Moss P, Hayward A, Copas A, Shallcross L. Shrotri M, et al. Among authors: azmi b. Lancet Infect Dis. 2021 Nov;21(11):1529-1538. doi: 10.1016/S1473-3099(21)00289-9. Epub 2021 Jun 23. Lancet Infect Dis. 2021. PMID: 34174193 Free PMC article.
SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI).
Stirrup O, Krutikov M, Tut G, Palmer T, Bone D, Bruton R, Fuller C, Azmi B, Lancaster T, Sylla P, Kaur N, Spalkova E, Bentley C, Amin U, Jadir A, Hulme S, Giddings R, Nacer-Laidi H, Baynton V, Irwin-Singer A, Hayward A, Moss P, Copas A, Shallcross L. Stirrup O, et al. Among authors: azmi b. J Infect Dis. 2022 Apr 16:jiac146. doi: 10.1093/infdis/jiac146. Online ahead of print. J Infect Dis. 2022. PMID: 35429382 Free PMC article.
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study.
Krutikov M, Stirrup O, Nacer-Laidi H, Azmi B, Fuller C, Tut G, Palmer T, Shrotri M, Irwin-Singer A, Baynton V, Hayward A, Moss P, Copas A, Shallcross L; COVID-19 Genomics UK consortium. Krutikov M, et al. Among authors: azmi b. Lancet Healthy Longev. 2022 May;3(5):e347-e355. doi: 10.1016/S2666-7568(22)00093-9. Epub 2022 May 4. Lancet Healthy Longev. 2022. PMID: 35531432 Free PMC article.
Autologous versus pooled human serum for articular chondrocyte growth.
Munirah S, Ruszymah BH, Samsudin OC, Badrul AH, Azmi B, Aminuddin BS. Munirah S, et al. Among authors: azmi b. J Orthop Surg (Hong Kong). 2008 Aug;16(2):220-9. doi: 10.1177/230949900801600219. J Orthop Surg (Hong Kong). 2008. PMID: 18725677 Free article.
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.
Krutikov M, Palmer T, Tut G, Fuller C, Azmi B, Giddings R, Shrotri M, Kaur N, Sylla P, Lancaster T, Irwin-Singer A, Hayward A, Moss P, Copas A, Shallcross L. Krutikov M, et al. Among authors: azmi b. Lancet Healthy Longev. 2022 Jan;3(1):e13-e21. doi: 10.1016/S2666-7568(21)00282-8. Epub 2021 Dec 16. Lancet Healthy Longev. 2022. PMID: 34935001 Free PMC article.
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.
Tut G, Lancaster T, Krutikov M, Sylla P, Bone D, Kaur N, Spalkova E, Bentley C, Amin U, Jadir AT, Hulme S, Butler MS, Ayodele M, Bruton R, Shrotri M, Azmi B, Fuller C, Irwin-Singer A, Hayward A, Copas A, Shallcross L, Moss P. Tut G, et al. Among authors: azmi b. Lancet Healthy Longev. 2021 Sep;2(9):e544-e553. doi: 10.1016/S2666-7568(21)00168-9. Epub 2021 Aug 19. Lancet Healthy Longev. 2021. PMID: 34430954 Free PMC article.
19 results